ofa semaglutide lawsuit Novo Nordisk is suing U.S. telehealth company Hims and Hers, alleging patent infringement over its planned release of a knockoff version of its Wegovy weight loss pill. Hims and Hers is pushing back, Ozempic and Similar Weight Loss

Research presented at the ACR Convergence 2025 conference showed that RA patients with elevated BMI who took GLP-1 receptor agonists experienced superior improvements in disease activity scores, pain levels, and weight loss compared to controls

Women with prior bariatric surgery, pregnancy before the index date, incomplete weight data, or other weight-loss medication use were excluded

The reason for FND attacks caused by COVID-19 vaccines has not been determined

Or is something else going on

What Makes This Study New According to the authors, this is the first randomized, double-blind, placebo-controlled trial to evaluate the full 2.4 mg dose of semaglutide in treatment-seeking adults with both obesity and alcohol use disorder

Specify whether it is a compounded version or a branded product like Ozempic or Wegovy